Answer
Home infusions of Soliris (eculizumab) may be considered for patients who have tolerated clinic infusions well, following evaluation and recommendation by the treating physician, and must be performed by a qualified healthcare professional.
Sources for this answer
- Soliris 300 mg concentrate for solution for infusionAlexion Pharma UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 29Document updated
Sources checked